CREATE: Cross-tumoral Phase 2 With Crizotinib

Clinical trial NCT01524926 · COMPLETED

Trial details

NCT number: NCT01524926
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma Locally Advanced and/or Metastatic Clear Cell Sarcoma Locally Advanced and/or Metastatic Alveolar Rhabdomyosarcoma

Start date: 2012-09-01
Primary completion: 2017-12-06
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.